Latest

Medical Properties Trust: The Case For A Turnaround (Archive)

Early-stage turnaround as improving fundamentals meet still deeply discounted valuations.

Block: Don't Buy Yet, Wait For Confident Commentary In Q1 (Archive)

Tariffs cloud Block’s growth outlook despite Cash App features and healthy Square trends.

Brookfield Asset Management: I Know It Looks Bullish But It's Not A Buy Right Now (Archive)

BAM’s improving portfolio and credit growth are offset by fair valuation and technical resistance.

Solid Power: Here's What To Do Now If You Missed Selling Earlier (Archive)

Deep-value SLDP faces long commercialization timelines, tightening liquidity, and tariff-driven OEM headwinds.

Morgan Stanley Direct Lending: Why Its Portfolio Is Relatively Insulated Vs. Tariffs (Archive)

Tariffs, rate cuts, and recession risks leave MSDL a higher‑risk neutral hold.

Eagle Point Credit: Why I'm Buying The Notes And Preferreds But Avoiding The Common Stock (Archive)

Risk-aware CLO credit strategy prioritizing resilient cash flows to safeguard downside.

Enbridge: Get In Now To Enjoy A Multi-Year Bull Run (Archive)

Enbridge is poised for outsized, resilient EBITDA growth and a potential multi-year bull run.